Johnson Pharmacare Limited has filed its quarterly compliance certificate with BSE Limited for the quarter ended 31st March, 2026, fulfilling regulatory obligations under SEBI depositories regulations. The pharmaceutical company, formerly known as Sun and Shine Worldwide Limited, submitted the mandatory documentation on 13.04.2026.

Regulatory Compliance Filing

The company submitted a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for Q4FY26. This regulation requires listed companies to provide quarterly certificates regarding the dematerialization of physical share certificates.

Certificate Confirmation

Satellite Corporate Services Private Limited, serving as the company's Registrar & Share Transfer Agent, issued the compliance certificate dated 06.04.2026. The certificate confirms that no physical share certificates were received for dematerialization during the quarter ended 31st March, 2026.

The registrar confirmed compliance with standard verification procedures, stating that securities comprised in certificates are listed on stock exchanges and that proper verification and cancellation processes are followed when physical certificates are processed for dematerialization.

Company Information

The submission was signed by Rajendra Prasad, Additional Director of Johnson Pharmacare Limited, ensuring proper authorization of the regulatory filing. This quarterly compliance demonstrates the company's adherence to SEBI regulations governing depositories and participants in the Indian securities market.

Johnson Pharmacare Limited announced the appointment of Ms. Parul Agrawal as Additional Non-Executive & Independent Director following its board meeting held on February 13, 2026. The appointment was made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Board Meeting Details

The board meeting was conducted on Friday, February 13, 2026, commencing at 12:15 P.M. and concluding at 12:45 P.M. The primary agenda focused on the appointment of Ms. Parul Agrawal as Additional Non-Executive & Independent Director with immediate effect.

Director Profile and Qualifications

Ms. Parul Agrawal brings professional expertise as a Company Secretary to strengthen the board's composition. The appointment aligns with corporate governance requirements and enhances the company's independent oversight capabilities.

Regulatory Compliance and Declarations

The appointment complies with SEBI Master Circular requirements and Schedule III of SEBI LODR Regulations. Ms. Agrawal has submitted a comprehensive non-debarment declaration confirming her eligibility to hold the director position.

The company has formally notified the Bombay Stock Exchange Limited regarding this appointment under scrip code 532154 with ISIN INE560F01022. Johnson Pharmacare Limited, incorporated in Gujarat with its registered office in Ahmedabad, continues to strengthen its governance framework through strategic board appointments that enhance oversight and compliance capabilities.